Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576752
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
Management of Patients with Heart Failure At Home After Hospital Discharge
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Contemporary Post-Discharge Management in Heart Failure At Home
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STRONGHOME
Brief Summary:
This study aims to assess whether patients with acute heart failure HF can achieve the same level of HF-therapies by digital follow-up at home as compared to hospital visits according to the STRONG-HF strategy Patients admitted to hospital with acute HF will be enrolled and randomized to either follow-up at the hospital out-patient clinic or digital follow-up at home
Detailed Description:
This study seeks to enhance the management of HF patients by demonstrating that follow-up and medication up-titration can be effectively carried out digitally at home thereby relieving the burden on healthcare systems and patients There exists a substantial knowledge gap in the implementation of life-saving HF drugs that have been shown to significantly reduce mortality in HF patients by as much as 73 Despite strong evidence from clinical trials and guidelines the utilization of optimal HF therapy among patients remains low The successful STRONG-HF trial demonstrated improved outcomes through early and rapid up-titration of HF medications and follow-up at specialized HF clinics after discharge and this strategy is now strongly recommended in the updated European Society of Cardiology Heart Failure Guidelines from 2023 However a major challenge was the need for patients to travel to the hospital for weekly visits which posed significant barriers for many patients especially in geographically dispersed regions due to travel distance immobility and logistical challenges To address this gap the STRONGHOME trial aims to conduct visits and rapid up-titration of medications in the patients home a strategy not previously tested in a clinical trial and with direct clinical implications The success of this approach has the potential to improve HF care globally and advance the field of implementation science in HF and other chronic diseases
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None